Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathology-Informed Augmentation Improves Cross-Cohort IMU-to-vGRF Estimation Between Healthy Adults and Adults With Osteoarthritis.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2026
Same author

QeITH: Quantifies Tumor Ecosystem Heterogeneity to Predict Cancer Progression and Treatment Benefit.

Computational and structural biotechnology journal·2026
Same author

Correction: Pseudolaric acid B induces G2/M phase arrest in canine mammary tumor cells by targeting CDK1.

Frontiers in veterinary science·2026
Same author

Generation of a Rabbit Anti-Canine CD19 Monoclonal Antibody From Peripheral Blood and Its Validation in Immunoassays and CAR-T Feasibility.

Veterinary and comparative oncology·2026
Same author

A foundation model for multi-task cross-distribution restoration of fluorescence microscopy images.

Nature communications·2026
Same author

Single-Camera Knee Adduction Moment Estimation for Individuals With Knee Osteoarthritis via a Novel Spatio-Temporal Graph Transformer Network.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2026

Related Experiment Video

Updated: Jun 2, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

ScSpTITH: a rank-correlation framework for robust quantification of multi-dimensional tumor heterogeneity.

Jiangti Luo1,2, Qiqi Lu1, Xiaobo Zhang3

  • 1Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.

Human Genetics
|June 1, 2026
PubMed
Summary

Intra-tumoral heterogeneity (ITH) drives cancer complexity and treatment resistance. Our new ScSpTITH tool robustly quantifies ITH using single-cell and spatial transcriptomics, revealing links to tumor evolution and poor outcomes.

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore
06:01

Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore

Published on: December 12, 2019

Related Experiment Videos

Last Updated: Jun 2, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore
06:01

Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore

Published on: December 12, 2019

Area of Science:

  • Genomics
  • Computational Biology
  • Cancer Research

Background:

  • Intra- and inter-tumoral heterogeneity (ITH) is a key driver of cancer progression and therapeutic resistance.
  • Single-cell RNA sequencing (scRNA-seq) offers high resolution but suffers from significant "dropout" artifacts, limiting accuracy.
  • Existing methods struggle to reliably quantify heterogeneity in complex cancer datasets.

Purpose of the Study:

  • To develop a robust computational framework, ScSpTITH, for quantifying ITH in both scRNA-seq and spatial transcriptomic data.
  • To address the challenges posed by technical noise and dropout artifacts in transcriptomic data.
  • To provide a unified approach for dissecting multi-dimensional tumor heterogeneity.

Main Methods:

  • ScSpTITH utilizes a rank-based strategy, selecting highly variable genes and computing pairwise Spearman rank correlations.
  • This method is inherently robust to technical noise, non-normality, and high dropout rates.
  • The framework is scalable and flexible, applicable to diverse cancer and developmental datasets.

Main Results:

  • Elevated ScSpTITH scores correlate strongly with active tumor evolution, advanced stage, and cellular plasticity.
  • ScSpTITH effectively quantifies heterogeneity across inter-tumoral and intra-tumoral dimensions, including spatial regions and cell populations.
  • The framework demonstrates robustness against high dropout rates common in scRNA-seq data.

Conclusions:

  • ScSpTITH provides a stable and interpretable method for quantifying transcriptional heterogeneity.
  • The framework links ITH quantification to critical clinical factors such as therapeutic resistance and poor patient outcomes.
  • ScSpTITH offers a unified computational solution for analyzing multi-dimensional heterogeneity in single-cell and spatial transcriptomic studies.